Iterum Therapeutics plc
NasdaqCM:ITRM
$ 1.55
$-0.03 (-1.90%)
$ 1.55
$-0.03 (-1.90%)
End-of-day quote: 05/03/2024

ITRM - Iterum Therapeutics Stock Prediction 2025 - 2030

6 years of reliable Iterum Therapeutics stock forecast. The Wall Street analysts predict Outperform for ITRM. See at a glance whether NasdaqCM:ITRM will rise in the future.

Forecast 2023
$1.80
Forecast 2025
$2.82
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
$1.80
Forecast 2030
$2.82
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
2.36
Price-to-book Ratio
N/A
Market Cap
0.02B
TEV
0.01 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$7.00
Country

Iterum Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Iterum Therapeutics Stock Forecast 2023

$6.50

In the last five quarters, Iterum Therapeutics’s Price Target has risen from $7.00 to $7.00 - a 0% increase. 0 analysts predict that Iterum Therapeutics’s share price will fall in the coming year, reaching $6.50. This would represent a decrease of -7.14%.

319.35%
319.35
Last update: 05/03/2024

Highest Price Target $7.00

Average Price Target $6.50

Lowest Price Target $6.00

Iterum Therapeutics Stock Prediction 2025

Iterum Therapeutics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $1.66. An increase of 7% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $1.67. An increase of 7.83% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $1.68. An increase of 8.66% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $1.70. An increase of 9.49% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $1.71. An increase of 10.32% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $1.72. An increase of 11.14% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $1.74. An increase of 11.97% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $1.75. An increase of 12.8% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $1.76. An increase of 13.63% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $1.77. An increase of 14.46% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $1.79. An increase of 15.28% compared to the previous month's estimate.

Iterum Therapeutics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $1.80. An increase of 16.11% compared to the previous month's estimate.

Iterum Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an Iterum Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $2.59. An increase of 67.37% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $2.61. An increase of 68.67% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $2.63. An increase of 69.96% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $2.65. An increase of 71.26% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be $2.67. An increase of 72.55% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $2.69. An increase of 73.85% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $2.71. An increase of 75.15% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $2.73. An increase of 76.44% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $2.75. An increase of 77.74% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $2.77. An increase of 79.03% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $2.80. An increase of 80.33% compared to the previous month's estimate.

Stock Forecast for the Price of an Iterum Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $2.82. An increase of 81.62% compared to the previous month's estimate.

P/E
0.00
Beta
2.36
Price-to-book Ratio
N/A
Market Cap
0.02B
TEV
0.01 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$7.00
Country

Iterum Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Iterum Therapeutics plc?

The following analysts have recently covered Iterum Therapeutics:

H.C. Wainwright & Co.
Maxim Group
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Iterum Therapeutics plc?

The following sell-side analysts have recently covered Iterum Therapeutics:

Arce, Antonio Eduardo
McCarthy, Jason Wesly
(This information refers to the last 90 days.)